Print this page    •   Back to Web version of article

Drug Majors Agree on Price Cuts for AIDS Drugs in Burkina Faso

May 10, 2001

Burkina Faso's Health Minister Pierre Tapsoba said on Wednesday that an agreement had been reached between Bristol Myers Squibb, GlaxoSmithkline and Merck Sharp and Dome to lower the price of antiretroviral drugs by up to 96 percent. Tapsoba stressed that despite the drop in price, the average person in the country would still not be able to afford the drugs. Burkina Faso follows the Ivory Coast as the West African country most affected by HIV/AIDS with 7.7 percent of the population HIV-positive.


Back to other CDC news for May 10, 2001

Previous Updates

Excerpted from:
Agence France Presse
05.10.01




This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art19563.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.